Ratan Tata invests in medtech startup Axio Biosolutions

By: |
New Delhi | Updated: January 26, 2018 12:40:12 PM

Axio Biosolutions has raised $7.4 million in a Series B funding round led by Ratan Tata's RNT Capital along with existing investors Accel Partners and IDG Ventures India, a company statement said here on Friday.

ratan tata, tata, tata company, tata power, ratan tata investment, tata consultancy services, TCS, tata investment, tata funding, series b funding, RNT capital, accel partners, IDG ventures india, Axio, Axio biosolutionsHeadquartered in Boston, Axio Biosolutions has its corporate office in Bengaluru and GMP certified manufacturing facility in Gujarat. (Reuters)

Axio Biosolutions has raised $7.4 million in a Series B funding round led by Ratan Tata’s RNT Capital along with existing investors Accel Partners and IDG Ventures India, a company statement said here on Friday. The company plans to use the funds for expansion to new markets, while continuing to work on high-impact medical products. Masterkey Holdings was the advisor for the transaction. Axio had earlier launched an emergency haemostat for trauma care. Headquartered in Boston, Axio Biosolutions has its corporate office in Bengaluru and GMP certified manufacturing facility in Gujarat.

(Further details awaited)

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.